Anatoly Dritschilo

USPTO Granted Patents = 24 (Patent Applications = 8)

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 6 (Patent Applications = 8)

Average Co-Inventor Count = 4.2

ph-index = 8

Forward Citations = 236(Granted Patents)

Location History:

Washington, DC (US) (2003)
Rockville, MD (US) (2017 - 2023)
Bethesda, MD (US) (1996 - 2024)

Company Filing History:

15 out of 484

Georgetown University

patents

9 out of 9

Shuttle Pharmaceuticals, Inc.

University of Illinois

patents

where one patent can have more than one assignee

Years Active: 1996-2025

Loading Chart...

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12357650 - Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorlylase inhibitors in combination with radiation (2025-07-15),

2. 12077515 - Selective histone deacetylase inhibitors for the treatment of human disease (2024-09-03),

3. 11654157 - Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorylase inhibitors in combination with radiation (2023-05-23),

4. 11584733 - Selective histone deacetylase inhibitors for the treatment of human disease (2023-02-21),

5. 11407723 - Selective histone deacetylase inhibitors for the treatment of human disease (2022-08-09),

6. 11034667 - Selective histone deacetylase inhibitors for the treatment of human disease (2021-06-15),

7. 10745352 - Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof (2020-08-18),

8. 10730834 - Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof (2020-08-04),

9. 9809539 - Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof (2017-11-07),

10. 8748463 - Histone deacetylase inhibitors and methods of use thereof (2014-06-10),

11. 8653278 - Isoform selective HDAC inhibitors (2014-02-18),

12. 8293513 - Histone deacetylase inhibitors (2012-10-23),

13. 8222451 - Histone deacetylase inhibitors and methods of use thereof (2012-07-17),

14. 7842835 - Histone deacetylase inhibitors and methods of use thereof (2010-11-30),

15. 7442520 - Gene BRCC-3 and diagnostic and therapeutic uses thereof (2008-10-28),

Title: The Innovative Journey of Anatoly Dritschilo

Introduction: Anatoly Dritschilo, a distinguished inventor based in Bethesda, MD (US), has made significant contributions to the field of innovation and patents.

Latest Patents: Anatoly Dritschilo holds several patents in the medical field, focusing on advancements in cancer treatment and radiation therapy.

Career Highlights: With a career spanning several decades, Dritschilo has been a pioneer in developing cutting-edge technologies for cancer research and treatment. His work has led to groundbreaking discoveries in the fight against cancer.

Collaborations: Throughout his career, Anatoly Dritschilo has collaborated with leading researchers, medical professionals, and institutions to further the impact of his inventions. His collaborative efforts have resulted in the development of innovative solutions with real-world applications.

Conclusion: Anatoly Dritschilo's dedication to innovation and his relentless pursuit of advancements in cancer treatment have solidified his reputation as a visionary inventor in the medical field. His work continues to inspire future generations of inventors and researchers in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.